Also known as Zometa and Reclast
Zoledronic acid (INN) or zoledronate (marketed by Novartis under the trade names Zometa, Zomera, Aclasta and Reclast) is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases.Source: Wikipedia
Estimated Total Cost: $835.23 for an average of 28 days supply
Patients are most commonly prescribed zoledronic acid to treat breast cancer, metastatic cancer, multiple myeloma, and prostate cancer.